Abstract:figure legend Human intestinal organoids were genetically modified to express a fluorescent protein in enteroendocrine cells (EECs), which were then separated by flow cytometry and analysed by single‐cell RNA sequencing. High numbers of human EECs were thereby available for cluster analysis and differential gene expression, revealing transcriptomic differences between EEC populations. Gut hormones control intestinal function, metabolism and appetite, and have been harnessed therapeutically to treat type 2 diabetes and obesity. Our understanding of the enteroendocrine axis arises largely from animal studies, but intestinal organoid models make it possible to identify, genetically modify and purify human enteroendocrine cells (EECs). This study aimed to map human EECs using single‐cell RNA sequencing. Organoids derived from human duodenum and ileum were genetically modified using CRISPR‐Cas9 to express the fluorescent protein Venus driven by the chromogranin‐A promoter. Fluorescent cells from CHGA‐Venus organoids were purified by flow cytometry and analysed by 10X single‐cell RNA sequencing. Cluster analysis separated EEC populations, allowing an examination of differentially expressed hormones, nutrient‐sensing machinery, transcription factors and exocytotic machinery. Bile acid receptor GPBAR1 was most highly expressed in L‐cells (producing glucagon‐like peptide 1 and peptide YY), long‐chain fatty acid receptor FFAR1 was highest in I‐cells (cholecystokinin), K‐cells (glucose‐dependent insulinotropic polypeptide) and L‐cells, short‐chain fatty acid receptor FFAR2 was highest in ileal L‐cells and enterochromaffin cells, olfactory receptor OR51E1 was notably expressed in ileal enterochromaffin cells, and the glucose‐sensing sodium glucose cotransporter SLC5A1 was highly and differentially expressed in K‐ and L‐cells, reflecting their known responsiveness to ingested glucose. The organoid EEC atlas was merged with published data from human intestine and organoids, with good overlap between enteroendocrine datasets. Understanding the similarities and differences between human EEC types will facilitate the development of drugs targeting the enteroendocrine axis for the treatment of conditions such as diabetes, obesity and intestinal disorders. Key points Gut hormones regulate intestinal function, nutrient homeostasis and metabolism and form the basis of the new classes of drugs for obesity and diabetes. As enteroendocrine cells (EECs) comprise only ∼1% of the intestinal epithelium, they are under‐represented in current single‐cell atlases. To identify, compare and characterise human EECs we generated chromogranin‐A labelled organoids from duodenal and ileal biopsies by CRISPR‐Cas9. Fluorescent chromogranin‐A positive EECs were purified and analysed by single‐cell RNA sequencing, revealing predominant cell clusters producing different gut hormones. Cell clusters exhibited differential expression of nutrient‐sensing machinery including bile acid receptors, long‐ and short‐chain fatty acid receptors and glucose transporters. Organoid‐derived EECs mapped well onto data from native intestinal cell populations, extending coverage of EECs.

Enteroendocrine K and L cells in healthy and type 2 diabetic individuals

Expression of Bile Acid Receptors and Transporters Along the Intestine of Patients With Type 2 Diabetes and Controls

Single cell transcriptomic profiling of large intestinal enteroendocrine cells in mice - Identification of selective stimuli for insulin-like peptide-5 and glucagon-like peptide-1 co-expressing cells

Revisiting the concept of incretin and enteroendocrine L-cells as type 2 diabetes mellitus treatment

Disordered Control of Intestinal Sweet Taste Receptor Expression and Glucose Absorption in Type 2 Diabetes

Distribution and hormonal characterization of primary murine L cells throughout the gastrointestinal tract

Analysis of enteroendocrine cell populations in the human colon

Inuit population have shorter gastric emptying, higher duodenal motility and altered pan-enteric micromilieu: a comparative study between Greenlandic and Danish populations with and without type 2 diabetes

Elevated Glucagon-like Peptide-1 Receptor Level in the Paraventricular Hypothalamic Nucleus of Type 2 Diabetes Mellitus Patients

Insulin Secretion in Healthy Subjects and Patients with Type 2 Diabetes - Role of the Gastrointestinal Tract

Intestinal expression profiles and hepatic expression of LEAP2, ghrelin and their common receptor, GHSR, in humans

Inter-organ crosstalk during development and progression of type 2 diabetes mellitus

K-cells and glucose-dependent insulinotropic polypeptide in health and disease

Quantitative analysis of Tr1 lymphocytes in patients with type 2 diabetes mellitus

Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes

Type 1 diabetes human enteroid studies reveal major changes in the intestinal epithelial compartment

Colonic L-cell impairment in aged subjects with type 2 diabetes leads to diminished GLP-1 production

Enterotype Bacteroides Is Associated with a High Risk in Patients with Diabetes: A Pilot Study

Aberrant intestinal microbiota in individuals with prediabetes

Single‐cell transcriptomics of human organoid‐derived enteroendocrine cell populations from the small intestine

Intestinal glucagon-like peptide-1: A new player associated with impaired counterregulatory responses to hypoglycaemia in type 1 diabetic mice